Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms.
about
Pharmacogenetics in inflammatory bowel diseaseEffects of single nucleotide polymorphisms on human N-acetyltransferase 2 structure and dynamics by molecular dynamics simulationAnalysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversityThe Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and MetabolismShould we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background.The pharmacogenetics of NAT: structural aspects.Arylamine N-acetyltransferases and drug response.Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan populationFive-aminosalicylic Acid: an update for the reappraisal of an old drugNo association between variant N-acetyltransferase genes, cigarette smoking and Prostate Cancer susceptibility among men of African descentDapsone-associated methemoglobinemia in a patient with slow NAT2*5B haplotype and impaired cytochrome b5 reductase activity.NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control studyThe pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid.Crohn's disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene.Orofacial cleft risk is increased with maternal smoking and specific detoxification-gene variants.Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2.Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2.Genetic polymorphisms of N-acetyltransferase 2 and colorectal cancer risk.Arylamine N-acetyltransferases: what we learn from genes and genomes.Characterization of genetic variation and natural selection at the arylamine N-acetyltransferase genes in global human populations.Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.Pharmacogenetics of antiarrhythmic therapy.Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk.Effects of single nucleotide polymorphisms in human N-acetyltransferase 2 on metabolic activation (O-acetylation) of heterocyclic amine carcinogens.N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review.N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.Maternal smoking and oral clefts: the role of detoxification pathway genesDaily Rhythm in Plasma N-acetyltryptamine.Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines.Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity.Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.Functional genomics of C190T single nucleotide polymorphism in human N-acetyltransferase 2.Insight into the structure of Mesorhizobium loti arylamine N-acetyltransferase 2 (MLNAT2): a biochemical and computational study.Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
P2860
Q28246002-7ECF37DE-EF11-4FB0-9972-3193EC27F86FQ28477297-99C7C3C8-744D-4E25-8D60-D5F6E31D0DECQ28744372-0ACFAC15-37DB-4579-9BF5-4DFB3BB76171Q28822540-D9142FAA-1809-4721-8070-ECF990549F44Q33770163-5C9F1432-DD45-4772-AE5C-21592257F37BQ34414220-368BF257-FA88-4616-96DE-8C7707F49075Q34609118-A6F86D16-6B11-4278-AB51-639A5853B9F4Q34673370-A24FCEA2-C641-4534-9D0B-CFA4153C3D6EQ34986858-24AF79F9-41AA-4064-BD42-540804465F25Q35061210-C7CFBEE7-6523-48C3-A16D-E99FE8022F1FQ35065344-14C3A33A-88CD-4975-99E1-859466C44516Q35156818-4278FA6B-03B8-4EDC-8CAC-739BD4944835Q35233775-C168049C-228A-4487-BA75-3B68E6461E4DQ35238140-27066CE1-E4F3-4060-892B-CCF6DA7C7109Q35435673-89B9B9A7-B692-4760-8DE5-C414F9270401Q35616533-BE73FD8E-8649-4C57-8689-9B5198323992Q35774965-852539FE-02F9-45AE-BD2A-AADCF385CC87Q36007941-427F311B-BD80-4BFE-A7D4-453EBE2CD6BFQ36158505-1E470577-DB1D-47AE-8896-D9ED9FA609D5Q36190549-D8A0F98E-9FDC-49B0-890C-CF0AA307B13FQ36300809-60A217BF-D76D-4C11-8497-3D7F0DDEBDE5Q36301606-F1723185-13E5-41BD-B1E6-50FB6500F91BQ36326202-5A55B5C4-B632-4DD9-B59D-31E8D80C3B41Q36548713-9249957F-E741-4520-8E87-030E108437CDQ36589391-106373EB-7E01-414D-9E39-77F978D59206Q36828813-C6F46746-CEC6-415F-80FB-CC37293BA327Q36948550-DC8457CE-EBCC-4881-A2B5-6C81B68E1206Q36969877-F06C725B-2403-422F-8F25-6EBE15D30C56Q37434505-D02C7F89-AA58-42C1-B6BD-E2234A81742BQ38501680-78A9109A-7DBB-43B9-9F6B-3300F825687FQ38983589-04BC7F23-A9A3-4542-91F0-852F1244164CQ41416067-C4AB7457-5DFF-4021-8ADC-7DB0E36A1A88Q41440380-0EAFC6CC-903C-4320-8EE2-4FAC9394FC32Q41522736-D34066C9-DB63-4535-95DF-15CFCE83D2D2Q41764388-57905E51-62A9-49A9-9484-B6B036B1DC41Q41788289-A1CA662E-5C64-4D65-9E78-CEA35D071EE3Q43611407-9D094451-2D7C-421A-ABF6-9AD767CCF5B7Q44131881-E7D99771-7ACA-457B-AA10-3EA12105DC13Q46972466-4F55B64E-FBC0-4E04-BB96-74C154332805Q48123467-4100DDA9-6C29-4FFD-AF71-D9259A7E7B50
P2860
Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Functional characterization of ...... ngle nucleotide polymorphisms.
@en
Functional characterization of human N-acetyltransferase 2
@nl
type
label
Functional characterization of ...... ngle nucleotide polymorphisms.
@en
Functional characterization of human N-acetyltransferase 2
@nl
prefLabel
Functional characterization of ...... ngle nucleotide polymorphisms.
@en
Functional characterization of human N-acetyltransferase 2
@nl
P2093
P1476
Functional characterization of ...... ngle nucleotide polymorphisms.
@en
P2093
P304
P356
10.1097/00008571-200104000-00004
P577
2001-04-01T00:00:00Z